Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep472 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

AKR1D1 regulates androgen availability in vitro by generating metabolites that are unable to activate the androgen receptor

Gangitano Elena , Storbeck Karl , Nikolaou Nikolaos , Tomlinson Jeremy

Introduction: AKR1D1 is a 5β-reductase that sits at the interface of steroid hormone metabolism and primary bile acid biosynthesis. 5β-reduced androgens are widely believed to be inactive, but to our knowledge there are currently no data that have directly tested their ability to activate the androgen receptor (AR). We therefore wanted to test the ability of AKR1D1 to regulate androgen availability in vitro and to determine if 5β-reduced androgens are a...

ea0041gp184 | Reproduction & Endocrine Disruption | ECE2016

Impaired DHEA sulfation defines androgen excess in women with polycystic ovarian syndrome (PCOS)

Kempegowda Punith , O'Reilly Michael W , Hassan-Smith Zaki , Storbeck Karl-Heinz , Taylor Angela E , Arlt Wiebke

Context: Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in women of classic androgen synthesis. Recent work has highlighted that impaired DHEA sulfation results in enhanced androgen production. Here, we evaluated the relationship between DHEA and DHEAS and androgen excess and metabolic phenotype in PCOS.Patients and methods: We compared 65 women with PCOS to 35 healthy women matched for age and body mass index (BMI). All subject...

ea0059p194 | Reproduction | SFEBES2018

Investigating the roles of steroids in gonadal development and maintenance using an androgen and cortisol deficient zebrafish model

Oakes James , Li Nan , Wistow Belinda , Storbeck Karl-Heinz , Cunliffe Vincent , Krone Nils

Sex development in zebrafish is highly plastic, making this species an ideal model for investigation of endocrine disruption and gonadal development and function. However, the hormonal regulation of these processes in zebrafish is poorly understood. We have used a model of androgen and glucocorticoid deficiency to explore these processes. In humans, ferredoxin (FDX1) is an electron-providing cofactor required for steroid biosynthesis. The zebrafish homologue of FDX1, ...

ea0077p55 | Metabolism, Obesity and Diabetes | SFEBES2021

A novel approach to serum multi-steroid profiling using ultra high-performance liquid chromatography-tandem mass spectrometry with post column infusion ammonium fluoride

Shaheen Fozia , Gilligan Lorna , Schiffer Lina , Storbeck Karl-Heinz , Hawley James , Keevil Brian , Arlt Wiebke , Taylor Angela

Comprehensive multi-steroid profiling offers a powerful tool for the investigation, diagnosis and management of steroidogenic disorders by simultaneously quantifying multiple steroids from several pathways of steroid biosynthesis and metabolism. Difficulties can arise when optimising chromatography and mass spectrometry conditions for many analytes in a single method. Low concentrations of ammonium fluoride have previously been shown to enhance the sensitivity of select analyt...

ea0081p27 | Adrenal and Cardiovascular Endocrinology | ECE2022

Multiplex serum steroid profiling using liquid chromatography mass spectrometry with post column infusion ammonium fluoride

Schiffer Lina , Shaheen Fozia , Gilligan Lorna , Storbeck Karl , Hawley James M , Keevil Brian , Arlt Wiebke , Taylor Angela

Background: Development of multi-steroid profiling allows comprehensive investigation into the different branches of steroid metabolism. Immunoassays only allow analysis of a single steroid per assay and suffer from problems with specificity due to cross reactivity of similar steroids. Liquid-chromatography mass spectrometry has the specificity to analyse multiple steroids in a single experiment and the dynamic range to quantify steroids at high concentrations such as those ob...

ea0065oc1.1 | Metabolism and Obesity | SFEBES2019

Intracrine activation of 11-oxygenated androgens by AKR1C3 modulates lipid metabolism in human female adipose tissue

Schiffer Lina , Sinclair Alexandra J , O'Reilly Michael W , Westgate Connar , Mashood Afeefa , Palmer Elliot , Gilligan Lorna C , Singhal Rishi , Taylor Angela E , Dunn Warwick B , Arlt Wiebke , Storbeck Karl-Heinz

Polycystic ovary syndrome (PCOS) affects 10% of women and is associated with an increased risk of type 2 diabetes and fatty liver disease. Androgen excess is an important driver of metabolic risk in PCOS. In adipose tissue from women with PCOS, increased activation of androstenedione (A4) to testosterone (T) by the enzyme AKR1C3 results in systemic lipotoxicity. Recent in-vitro studies also demonstrated that T and 11-ketotestosterone (11KT) activate the androgen recep...